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SUMMARY.-The presence of sex chromatin in a metastatic malignant
melanoma from a male patient aged 26 who showed no evidence of any con-
stitutional chromosome anomaly is described. A possible association between
the apparently
" female
" origin of the tumour and the good response to therapy
is considered.
TU.'%1OTJRS ofmales, apart from teratomas, do notgenerally show sex chromatin
(Tavares, .11.466; Atkin, 1967). We found only one chromatin-positive tumour
among 311 non-teratomatous malignant tumours studied by a squash techiiique;
this was an oesophageal carcinoma in a patient aged 71 whoproved to be an unsus-
pected case ofKlinefelter'ssyndrome with a 47,XXYkaryotype (Atkin and Baker,
1965). The present tumour shows the appearances of sex chromatin in the tumour
cells, but studies on the patient's normal cells have revealed no evidence of a
constitutional chromosome anomaly. The case is also notable for the good out-
come oftreatment; thepatient is well 41 years after removal oftheprimary tumour 2
in spite ofthe subsequent appearance of metastases.
CASE REPORT
C.B., aged 26, a clerk, gave a history of a raised pigmented spot of uncertain
duration in the right dorsi-lumbar region wbich had recently bled. The lesion,
I cm. in diameter, was excised in September 1966; the bistological appearances
were those of malignant melanoma (Fig. 1). In April 1967, a lump which had
appeared over the right I Ith rib in the anterior axillary line was excised; on
histological examination this proved to be a lymph node replaced by malignant
melanoma. Twomonthslater,ablockdissectionoftherightaxillawasperformed:
a number ofenlarged lymph nodes were removed, most of which were found to be
invaded by amelanotic malignant melanoma although two from the apex of the
axilla were free from tumour. The patient was given a postoperative course of
telecaesium therapy to the axilla. In October 1967, a nodular indurated area,
recurrence, ? inflammation, was present in the axilla. A course oftetracycline
-was then giveii. At this time a 32P uptake test showed some concentration over
the nodules which, however, was insufficient to warrant a therapeutic dose of 32P.
A course of melphalan, 5 mg. t.d.s. reduced to 2 mg. t.d.s. after 5 days, was then
begun. Four days after commencing the melphalan, enlargement of the right
breastappeared; the induration in the axilla also increased and an abscessappeared
which was incised. A month later, the axillary condition had greatly improved;488 N. B. ATKIN
a biopsy of the breast was then performed which showed the histological appear-
ances ofgynaecomastia (December, 1967).
Throughout the subsequent follow-up period of 38 months, the patient has
remained well and free from recurrence. During most of the first 21 months of
thisperiod, he was on adaily dose of 2 mg. ofmelphalan; the iiielphalan was then
discontinued.
Family andPreviou8ffi8tory
His father had died of carcinoma of the mouth; his mother, now aged 67, is
well. Three brothers and three sisters are alive and well. The patient has had
no illnesses ofnoteapartfrom
" congestion ofthelungs
" on one occasion. He has
been married for 3 years, but has no children.
CYTOGENETIC INVESTIGATIONS
Se,x chromatin
Metastatic tumourremoved in March andJune 1967 showedthe presence ofsex
chromatin; the method ofpreparation and assessment, using squash preparatiohs
stained in aceto-orcein, has been previously described (Atkin, 1967). In approxi- mately 60% of nuclei that were suitable for assessment, i.e,. free from multiple
chromocentres, two Barr bodies were seen (Fig. 2a). After an interval of 2 years,
a
" blind
" reassessment of the original slides, which were coded and examined
together with slides ofsimilar age from 16 other malignant cases, six male and 10
female, was made. The sex chromatin findings on all slides were in agreement with those obtained at the original examination.
Histological sections oftheprimary tumour andthe firstspecimen ofmetastatic
tumour were unsuitable for sex chromatin assessment, but those ofthe metastatic
tumour removed in June 1967 ishowed chromocentres compatible in appearance with sex chromatin in tumour cells (Fig. 2b).
Sex chromatin was not seen in fibroblasts in the tumour material, epithelial cells in a buccal smear, orepithelial and stromal cells in the breast tissue removed
in December 1967. No drumsticks were found among 300 polymorphs in a blood
smear.
ChroM0809ne 8tudie8
Tumour material removed in March and June 1967 and processed by a direct
method (Atkin and Baker, 1966) showed on both occasions a modal number of 68
chromosomes, with similarkaryotype changes including two large markers one of
EXPLANATION OF PLATES
FIG. I.-Histological section of the primary tumour. H. and E. (a) x 6; (b) x 530.
FIG. 2.-Sex chromatin in metastatic tumour (June 1967): (a) orcein squash preparation. Left: x 500; Right: x 1240. (b) histological section. x 2830. Two bodies are usually present.
FIG. 3.-Partial karyotypes of four metaphases from: (a) metastatic tumour (top: April 1967; others: June 1967). Left to right: two different markers, two Al and five G group chromo-
somes. Arrows indicate secondary constriction in one of the markers. (b) fibroblast
culture: G group chromosomes from diploid metaphases in fibroblast culture. The Y
chromosome is on the right of each row.
FIG. 4.-Protruding chromosome arins inhistological section of the primary tumour. (a) and
(b) metaphases; (c): anaphase; (d): telophase. H. and E. x 1500.BRITISH JOURNAL OF CANCER. Vol. XXV, No. 3.
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which frequently showed a prominent secondary constriction (Fig. 3a). Meta-
phases, anaphases and telophases in the sections frequently showed chromosomal
protrusions suggesting the presence of large marker chromosomes (Brandilo
and Atkin, 1968); these protrusions were clearly seen in the primary lesion which
had a high mitotic index (Fig. 4). The modal number of C group chromosomes
was 24. Other karyotypic features most commonly present were: two Al,
three A2, two A3, five B, nine D, four E16, four E17/18, eight F and five G group chromosomes. Unfortunately, no attempt was made to identify any late-
labelling C group chromosomes autoradiographically. Twelve out of 41 and 23
out of 35 metaphases in the two preparations hadapparently normal malediploid karyotypes;presumably these were fibroblasts orothernormalcells. Chromosome
studies on a blood leucocyte and skin fibroblast culture showed no abnormality; there were no hyperdiploid counts among 43 and 39 metaphases in the respective preparations andanalysis of 9 and 15 metaphasesrespectively showed malediploid karyotypes. A Y chromosome could frequently be identified in thediploid cells,
especially in the fibroblast culture (Fig. 3b); the chromosomes of the aneuploid
tumour cells were, however, of less good quality, and it was uncertain whether a
Y chromosome was present (Fig. 3a).
Application of the quinacrine fluorescence test (Pearson, Bobrow and Vosa,
1970; Atkin, 1970) to tumourandleucocyte-culture materialrevealed aninterphase Y chromatin body in normal cells (fibroblasts and lymphocytes) but none was
seen in tumour cells. However, in view ofthe age of the material when this test
was applied it is uncertain whether the failure to observe a fluorescent chromo-
centre indicates absence of a Y chromosome in the tumour cells.
Micro-spectrophotometric investigations
Estimation of the Feulgen-DNA content of interphase tumour cells (April and June 1967) showed on each occasion a modal value corresponding to a near-
triploid chromosome number.
8ex chromatin studies on other malignant tumours of male-s
Excluding the present case and thepatient ivith Klinefelter'ssyndromealready mentioned, sex chromatin has been looked for in squash preparations from 494
malignant tumours of males including those reported in previous studies (Atkin and Baker, 1965; Atkin, 1967). Apart from a thyroid carcinoma which could
not be assessed because ofthe presence ofmultiple chromocentres innearly all the
tumour cells, all these tumours were sex-chromatin-negative; they include nine
malignant melanornas.
DISCUSSION
Although a number of authors have studied the chromosomes of malignant melanoma cells (Whang-Peng, Chretien and Knutsen, 1970; Miles, 1967; Spriggs, Boddington and Clarke, 1962; Berger, 1968; Quiroz Gutie'rrez, Montailo Islas and
Hidalgo Robles, 1968), sex chromatin studies appear to be lacking, as do auto-
radiographic studies with a view to determining whetherlate-labelling X chromo-
somes are present. Sex chromatin studies in this laboratory suggest that, excluding testicular teratomas and occasional tumours in subjects with congenital chromosome anomalies involving the presence of additional X chromosomes,490 N. B. ATKIN
chromatin-positive malignant tumours in males are of very rare or doubtful
occurrence. However, since in addition to the present positive case only nine
other malignant melanomas in males (all negative) were studied, the possibility
that these tumours are relatively frequently chromatin-positive must still be
considered.
The origin of the sex chromatin in the tumour cells and its relation, if any, to
the genesis and behaviour ofthe tumouris uncertain. Although no evidence of a
constitutional chromosome mosaicism was obtained from either chromosome
studies on the patient's normal cells (leucocytes and fibroblasts in culture, and
stromal cells in the tumour preparations), sex chromatin studies on his buccal
epithelium, breast tissue and tumour stroma, or a search for drumsticks in neutro-
phils, the possibility that the patient nevertheless was constitutionally a mosaic
or chimaera cannot be excluded. Ifthe tumourdeveloped from a cell-linehaving
two or three X chromosomes, and presumably a chromosome number in either
the diploid or triploid region, evidence of the persistence of this cell-line was not
forthcoming from the cytogenetic studies made on the patient's normal cells;
if the cells of this hypothetical cell-line contained only one heteropycnotic X
chromosome, it is presumed, in view of the presence of tu-o sex chromatin bodies
in the tumour cells, that a duplication of this chromosome occurred during the
chromosome changes which accompanied the development of the tumour. The
presence of double sex chromatin in the tumour cells would thus be a secondary phenomenon related to the chromosome changes accompanying the neoplastic transformation, as it appears to be in those tumours offemales which show double
sex chromatin (Atkin, 1967).
The appearance of unilateral gynaecomastia 14 months after excision of the
primary tumour is ofinterest, but itssignificance in relation to thedevelopment of
the tumour or the therapy is uncertain.
Malignant melanoma is a class of tumour that presents several noteworthy features. Some casesshow afamilialincidence(Lynch andKrush, 1968;Andrews,
1968) and the condition has been reported in identical twins from a set oftriplets (St-Arneault etal., 1970). Thehereditaryvarietymaybecharacterizedbymultiple primarytumours, and there may be an associationwith varioushereditarydiseases
(Lynch andKrush, 1968). Thefrequency ofneoplastic disease at all sites may be
increased among relatives ofmalignant melanomapatients (TosoniDalai, Ronzoni
Bernardi, and Meneghelli, 1969). The prolonged survival of patients 'with
malignant melanoma in which the tumour has recurred or metastasised is well-
attested; Hendrix (1969) found 35 examples of
" unusual survival
" among 216
such cases. Further, there is nowgood evidence that a host reaction tomalignant melanoma, of an immunological nature, occurs in many patients (Lewis et al.,
1969; Fass et al., 1970; Romsdahl and Cox, 1970; Muna, Marcus and Smart, 1969). Among the rare tumours that have been observed to metastasise from
mother to foetus orplacenta, malignant melanoma isrelatively common (Brodsky et al., 1965). In one such case, the foetal metastases involuted spontaneously in
neonatal life (Cavell, 1963).
Manolov, Levan, Nadkarni, Nadkarni and Clifford (1970) described a Burkitt's
lymphoma, in an African boy aged 9 who subsequently succumbed to the disease, in which sex chromatin was present and alate-labelling C group chromosome was
demonstrated; the karyotypes of the tumour cells although aneuploid conformed
more closely to the female than to the male diploid karyotype. They cite threeSEX CHROMATIN POSITIVE MELANOMA IN A MALE 491
other Burkitt's lymphomas in which some or all the tumour cells directly or in
culture also showedapparently
" female
" karyotypes and consider the possibility
that in Burkitt's lymphoma the tumour may originate from
" transferred
"
cells (tumour cells carriedby mosquitoes from anotherpatient with the disease, or
normal cells derivedtransplacentally from the mother whichsubsequently became
malignant) andthat such anorigin fromforeign cells could accountforthe presence
of sex chromatin in the case cited by them and the good response to therapy in a
high proportion of cases. They mention that the latter feature is showed by one
other tumour wbich is the
" transplantation tumour par excellence ": the
choriocareinoma.
Patients with malignant melanoma, such as the present case, may also show a
dramatic response to therapy in which an immunological reaction may play a
part; both the unusual response and the presence of sex chromatin, suggesting an
origin from female cells, might be a consequence of a chimaeral condition, the
tumour having arisen from cells derived from the mother or perhaps from a twin
that failed to survive. If this is so, the presence of sex chromatin in malignant melanomas of males could provide a useful prognostic guide.
I thank Dr. P. Strickland and Mr. A. A. Shorter for their kind co-operation, Miss Marion C. Baker for the chromosome preparations and Mrs. C. T. Elledge for secretarial services. This work was supported by a grant from the Cancer
Research Campaign.
REFERENCES
A-WDREWS, J. C.-(1968) Archs Derm., 98, 282.
ATKIN, N.B.-(1967) Br. J. Cancer, 11,40.-(1970) Br. med.J., iv, 118.
ATKrN, N. B.ANDBAKER, M. C.-(1965) Lancet, i, 820.-(1966) J. natn. Cancer In8t., 36, 539.
BERGER, R.-(I968)
' Sur laMethodologie deI'Analyse des Chromosomes des Tumeurs
Thesis. La Faculte' des Sciences de Paris, pp. 67-99
BRAND-XO, H. J. S.ANDATKIN, N. B.-(1968) Br. J. Cancer, 22, 184.
BRODSKY, L., MARTIN, B., KAHN, S. B., LEwIs, G. ANDTELLum, M.-(1965) Cancer,
N.Y.) 18, 1048.
CAVELL, B.-(1963) Acta Paediat., Stockh., Suppl., 146, 37.
FASs. L., HERBERMAN, R. B., ZIEGLER, J. L. ANDKiRYABWIRE, J. W. M.-(1970) Lancet, i, 116.
HENDRIX, R. C.-(1969) Canar, N.Y., 24, 574.
LEwis, M. G., IKONOPISOV, R. L., NAMN, R. C., PHmLips, T. M., HAMILToN FAIRLY, G., BODENHAM, D. C.ANDALEXANDER, P.-(1969) Br. med. J., iii, 547.
LYNCH, H. T. ANDKiEtusH, A. J.-(1968) Can. med. A88. J., 99, 17.
MANOLOV, G., LiEvAN, A., NADKARN-1, J. S., NADKARNI, J. AND CLIFFORD, P.-(1970) Heredita,8, 66, 79.
MILES, C. P.-(1967) Cancer, N.Y., 20, 1253.
MUNA, N.M., MARCUS, S. AND SMART, C.-(1969) Cancer, N.Y.,23, 88.
PEARSON, P. L., BOBROW, M. AND VOSA, C. G.-(1970) Nature, Lond., 226, 78.
QU-IROZ GUTIE'RREZ) A., MONTARO ISLAS, G. ANDHi[DALGo ROBLES, I. N.-(1968) Revta
mgd. Ho8p. gen., Me'x., 31, 645.
ROMSDAHL, M. M. AND COX, I. S.-(1970) Arch8Surg., Chicago, 100, 491.
SPRIGGS, A. I., BODDrNGTON, M. M. AND CLARKE, C. M.-(1962) Br. med. J., ii, 1431.
ST-ARNEAU-LT, G., NAGEL, G., KiRKPATRICK, D., KiRKPATRICK, R. ANDHOLLAND, J. F.-(1970) Cancer, N.Y., 25, 672.492 N. B. ATKIN
TAVARES, A. S.-(1966) 'Sex Chromatin in Tumors'. In
' The Sex Chromatin ', edited
by K. L. Moore. London (W. B. Saunders Co.) pp. 405-433.
ToSONi DALAI, M. I., RONZONi BERNARDI, M. G. AND MENEGHELLI, P. L.-(1.969)
Tumori, 55, 161.
WHANG-PENG, J., CHRETIEN, P. AND KNUTSEN, T.-(1970) Cancer, N.Y., 25, 1216.